annual CAPEX:
$48.07M+$5.11M(+11.89%)Summary
- As of today (July 27, 2025), JAZZ annual capital expenditures is $48.07 million, with the most recent change of +$5.11 million (+11.89%) on December 31, 2024.
- During the last 3 years, JAZZ annual CAPEX has risen by +$2.54 million (+5.57%).
- JAZZ annual CAPEX is now -90.35% below its all-time high of $498.19 million, reached on December 31, 2022.
Performance
JAZZ CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$38.88M+$25.59M(+192.62%)Summary
- As of today (July 27, 2025), JAZZ quarterly capital expenditures is $38.88 million, with the most recent change of +$25.59 million (+192.62%) on March 1, 2025.
- Over the past year, JAZZ quarterly CAPEX has increased by +$21.98 million (+130.01%).
- JAZZ quarterly CAPEX is now -89.88% below its all-time high of $384.38 million, reached on December 31, 2022.
Performance
JAZZ quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$70.05M+$21.98M(+45.72%)Summary
- As of today (July 27, 2025), JAZZ TTM capital expenditures is $70.05 million, with the most recent change of +$21.98 million (+45.72%) on March 1, 2025.
- Over the past year, JAZZ TTM CAPEX has increased by +$15.00 million (+27.26%).
- JAZZ TTM CAPEX is now -85.94% below its all-time high of $498.19 million, reached on December 31, 2022.
Performance
JAZZ TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
JAZZ CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.9% | +130.0% | +27.3% |
| 3 y3 years | +5.6% | +4.3% | -13.2% |
| 5 y5 years | -73.6% | -82.3% | -82.6% |
JAZZ CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.3% | +11.9% | -89.9% | +893.2% | -85.9% | +63.0% |
| 5 y | 5-year | -90.3% | +11.9% | -89.9% | +893.2% | -85.9% | +63.0% |
| alltime | all time | -90.3% | +3302.0% | -89.9% | +893.2% | -85.9% | >+9999.0% |
JAZZ CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $38.88M(+192.6%) | $70.05M(+45.7%) |
| Dec 2024 | $48.07M(+11.9%) | $13.29M(+23.2%) | $48.07M(-23.6%) |
| Sep 2024 | - | $10.79M(+52.1%) | $62.88M(+11.5%) |
| Jun 2024 | - | $7.09M(-58.1%) | $56.40M(+2.5%) |
| Mar 2024 | - | $16.90M(-39.8%) | $55.04M(+28.1%) |
| Dec 2023 | $42.96M(-91.4%) | $28.10M(+553.7%) | $42.96M(-89.2%) |
| Sep 2023 | - | $4.30M(-25.1%) | $399.24M(+2.4%) |
| Jun 2023 | - | $5.74M(+19.0%) | $390.04M(-16.3%) |
| Mar 2023 | - | $4.82M(-98.7%) | $465.72M(-6.5%) |
| Dec 2022 | $498.19M(+994.2%) | $384.38M(-7941.2%) | $498.19M(+302.5%) |
| Sep 2022 | - | -$4.90M(-106.0%) | $123.78M(-20.1%) |
| Jun 2022 | - | $81.43M(+118.3%) | $154.90M(+92.1%) |
| Mar 2022 | - | $37.29M(+274.2%) | $80.66M(+77.1%) |
| Dec 2021 | $45.53M(-88.0%) | $9.97M(-62.0%) | $45.53M(-39.8%) |
| Sep 2021 | - | $26.22M(+265.3%) | $75.68M(+20.5%) |
| Jun 2021 | - | $7.18M(+231.1%) | $62.83M(-61.1%) |
| Mar 2021 | - | $2.17M(-94.6%) | $161.34M(-57.5%) |
| Dec 2020 | $379.25M(+108.0%) | $40.12M(+200.1%) | $379.25M(+9.5%) |
| Sep 2020 | - | $13.37M(-87.4%) | $346.28M(-14.0%) |
| Jun 2020 | - | $105.69M(-52.0%) | $402.49M(+18.9%) |
| Mar 2020 | - | $220.08M(+2983.6%) | $338.47M(+85.6%) |
| Dec 2019 | $182.34M(+38.7%) | $7.14M(-89.7%) | $182.34M(+1.1%) |
| Sep 2019 | - | $69.59M(+67.0%) | $180.35M(+57.2%) |
| Jun 2019 | - | $41.66M(-34.8%) | $114.70M(-39.1%) |
| Mar 2019 | - | $63.95M(+1141.9%) | $188.27M(+43.2%) |
| Dec 2018 | $131.47M(+15.4%) | $5.15M(+30.8%) | $131.47M(-8.2%) |
| Sep 2018 | - | $3.94M(-96.6%) | $143.20M(-35.7%) |
| Jun 2018 | - | $115.23M(+1511.9%) | $222.61M(+89.4%) |
| Mar 2018 | - | $7.15M(-57.6%) | $117.53M(+3.1%) |
| Dec 2017 | $113.95M(-37.9%) | $16.88M(-79.7%) | $113.95M(+15.9%) |
| Sep 2017 | - | $83.35M(+721.1%) | $98.35M(+203.7%) |
| Jun 2017 | - | $10.15M(+184.0%) | $32.38M(-81.6%) |
| Mar 2017 | - | $3.57M(+179.9%) | $175.79M(-4.2%) |
| Dec 2016 | $183.44M(+410.1%) | $1.28M(-92.7%) | $183.44M(-1.1%) |
| Sep 2016 | - | $17.38M(-88.7%) | $185.53M(+7.1%) |
| Jun 2016 | - | $153.56M(+1268.3%) | $173.30M(+428.8%) |
| Mar 2016 | - | $11.22M(+233.3%) | $32.77M(-8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $35.96M(-85.0%) | $3.37M(-34.7%) | $35.96M(-23.1%) |
| Sep 2015 | - | $5.16M(-60.4%) | $46.77M(-62.5%) |
| Jun 2015 | - | $13.02M(-9.6%) | $124.75M(-0.1%) |
| Mar 2015 | - | $14.41M(+1.7%) | $124.86M(-47.8%) |
| Dec 2014 | $238.97M(+1369.3%) | $14.17M(-83.0%) | $238.97M(+4.9%) |
| Sep 2014 | - | $83.14M(+533.1%) | $227.90M(+54.1%) |
| Jun 2014 | - | $13.13M(-89.8%) | $147.91M(+6.9%) |
| Mar 2014 | - | $128.53M(+4043.4%) | $138.35M(+750.6%) |
| Dec 2013 | $16.26M(-27.6%) | $3.10M(-1.6%) | $16.26M(-18.3%) |
| Sep 2013 | - | $3.15M(-11.6%) | $19.89M(-2.9%) |
| Jun 2013 | - | $3.57M(-44.6%) | $20.49M(-25.2%) |
| Mar 2013 | - | $6.44M(-4.3%) | $27.38M(+21.8%) |
| Dec 2012 | $22.48M(+288.9%) | $6.73M(+79.6%) | $22.48M(+27.5%) |
| Sep 2012 | - | $3.75M(-64.2%) | $17.62M(+14.7%) |
| Jun 2012 | - | $10.46M(+581.4%) | $15.36M(+150.9%) |
| Mar 2012 | - | $1.53M(-18.4%) | $6.12M(+6.0%) |
| Dec 2011 | $5.78M(+22.2%) | $1.88M(+26.5%) | $5.78M(+15.3%) |
| Sep 2011 | - | $1.49M(+21.9%) | $5.01M(+3.5%) |
| Jun 2011 | - | $1.22M(+2.4%) | $4.84M(+0.1%) |
| Mar 2011 | - | $1.19M(+7.0%) | $4.84M(+2.2%) |
| Dec 2010 | $4.73M(-21.8%) | $1.11M(-15.4%) | $4.73M(-28.6%) |
| Sep 2010 | - | $1.32M(+8.2%) | $6.62M(-9.7%) |
| Jun 2010 | - | $1.22M(+12.0%) | $7.34M(+19.6%) |
| Mar 2010 | - | $1.09M(-63.9%) | $6.13M(+1.3%) |
| Dec 2009 | $6.05M(-78.9%) | $3.01M(+48.1%) | $6.05M(-40.2%) |
| Sep 2009 | - | $2.03M(>+9900.0%) | $10.12M(+24.2%) |
| Jun 2009 | - | $12.00K(-98.8%) | $8.15M(-57.8%) |
| Mar 2009 | - | $1.00M(-85.8%) | $19.29M(-32.9%) |
| Dec 2008 | $28.74M(+812.6%) | $7.07M(>+9900.0%) | $28.74M(+26.6%) |
| Sep 2008 | - | $56.00K(-99.5%) | $22.71M(-2.3%) |
| Jun 2008 | - | $11.15M(+6.6%) | $23.25M(+74.3%) |
| Mar 2008 | - | $10.46M(+902.7%) | $13.34M(+323.5%) |
| Dec 2007 | $3.15M(+87.2%) | $1.04M(+75.9%) | $3.15M(+49.5%) |
| Sep 2007 | - | $593.00K(-52.3%) | $2.11M(+39.2%) |
| Jun 2007 | - | $1.24M(+358.3%) | $1.51M(+458.3%) |
| Mar 2007 | - | $271.00K | $271.00K |
| Dec 2006 | $1.68M(+19.0%) | - | - |
| Dec 2005 | $1.41M | - | - |
FAQ
- What is Jazz Pharmaceuticals plc annual capital expenditures?
- What is the all time high annual CAPEX for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual CAPEX year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly CAPEX year-on-year change?
- What is Jazz Pharmaceuticals plc TTM capital expenditures?
- What is the all time high TTM CAPEX for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc TTM CAPEX year-on-year change?
What is Jazz Pharmaceuticals plc annual capital expenditures?
The current annual CAPEX of JAZZ is $48.07M
What is the all time high annual CAPEX for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual capital expenditures is $498.19M
What is Jazz Pharmaceuticals plc annual CAPEX year-on-year change?
Over the past year, JAZZ annual capital expenditures has changed by +$5.11M (+11.89%)
What is Jazz Pharmaceuticals plc quarterly capital expenditures?
The current quarterly CAPEX of JAZZ is $38.88M
What is the all time high quarterly CAPEX for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly capital expenditures is $384.38M
What is Jazz Pharmaceuticals plc quarterly CAPEX year-on-year change?
Over the past year, JAZZ quarterly capital expenditures has changed by +$21.98M (+130.01%)
What is Jazz Pharmaceuticals plc TTM capital expenditures?
The current TTM CAPEX of JAZZ is $70.05M
What is the all time high TTM CAPEX for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high TTM capital expenditures is $498.19M
What is Jazz Pharmaceuticals plc TTM CAPEX year-on-year change?
Over the past year, JAZZ TTM capital expenditures has changed by +$15.00M (+27.26%)